1. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large B-cell lymphoma;Coiffier;N Engl J Med,2002
2. Phase III trial of rituximab-CHOP (RCHOP) vs. CHOP with a second randomization to maintenance rituximab (MR) or observation in patients 60 years of age and older with diffuse large B-cell lymphoma (DLBCL);Habermann;Blood,2003
3. Rituximab as first-line and maintenance therapy for patients with indolent non- Hodgkin's lymphoma;Hainsworth;J Clin Oncol,2002
4. Prolonged treatment with rituximab significantly improves event free survival and duration of response in patients with follicular lymphoma: a randomised SAKK trial;Ghielmini;Blood,2002
5. Mabthera (rituximab) plus CHOP is superior to CHOP alone in elderly patients with diffuse large B-cell lymphoma (DLCL): interim results of a randomized GELA trial;Coiffier;Blood,2000